Post-earnings recap
Reported
Wed, May 8, 2024
Est. EPS
—
Est. revenue
—
Implied move
—
EPS beat rate
63%
—
Est. EPS
—
Est. Rev
—
Impl. Move
—
CytomX Therapeutics reported a significant earnings surprise with an EPS of $0.17, which drove the stock up by 2.95%. However, no revenue figures were provided. The lack of management commentary or guidance leaves some uncertainty about future performance.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.17 | N/A | +393.10% |
| Revenue | — | N/A | — |
No transcript is on record for this earnings call, so the analysis is based solely on numerical results.